TrialClinical and translational science2021

A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.

Marina Baretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.